News Archive

Methodology of DNA-Free Swabs for Forensic Applications 05 May 2010: Swabs used for forensic purposes are designed for comparative sampling or securing traces at the crime scene, but swabs with DNA contamination can lead to mistakes in police investigations. This application note presents the Forensic-Swab from Sarstedt as DNA free with a test procedure based on a detection limit of 0.023ng DNA/μl extracted volume. SARSTEDT

Are Natural Products Delivering? Experiences and Recommendations from 27 Screening Campaigns 04 May 2010: In this application note from BioFocus, microbial strain subfractions are generated and used in high-throughput screens (HTS) for analysis with regard to diversity, selectivity and strain origin. Natural compounds were identified during the follow up of subfraction screening programs and their chemical properties have been analyzed. Searches in natural product databases revealed that 135 of the 645 identified natural compounds are novel compounds. BioFocus

Enter Tecan Competition and Win a Party for your Team! 04 May 2010: Send in a photo that captures how important your system is to your team to be in with a chance of winning a huge party for you and 20 of your colleagues. Tecan

Tecan Collaborates with Arizona State University to Rapidly Assess Radiation Exposure 30 Apr 2010: Tecan is collaborating with Arizona State University (ASU) to develop the Integrated Biodosimetry System, a prototype robotic system for rapid, high throughput screening to measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident. Tecan

Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System 29 Apr 2010: Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents. Roche's xCELLigence System has been used for studying cell viability and cell death when testing various cytotoxic compounds. Roche Diagnostics GmbH - a member of the Roche Group

Bioo Scientific Launches ELISAs for High-Throughput ApoB Quantitation 26 Apr 2010: Bioo Scientific introduces a new MaxDiscovery™ Apolipoprotein B (ApoB) ELISA Kit, a complete, two-step ELISA that analyzes the quantity of ApoB in tissues, serum, plasma or cultured cells for research purposes. This kit offers precise protein measurement along with the ability to analyze multiple samples in low-volume, high-throughput experiments. Bioo Scientific

BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor 12 Apr 2010: BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announces the expansion of its product portfolio with the addition of the BD Innova™ Preanalytical Automated Microbiology Specimen Processor, which is designed to help increase laboratory efficiency and automate the modern microbiology laboratory. BD Diagnostics

Caliper Introduces Micro CT System for Longitudinal Studies at AACR 2010 12 Apr 2010: Caliper Life Sciences will present its range of pre-clinical imaging products including the Quantum FX micro CT system. Caliper’s IVIS system dominates the preclinical imaging field with over 850 systems placed in laboratories worldwide for drug discovery and life science research. IVIS enables longitudinal in vivo studies with true 3D images of disease progression and therapeutic effect and minimal impact on the subject. Caliper Life Sciences

Pathway-Focused Gene Expression Panels Validated for Real-time PCR 07 Apr 2010: Fluidigm Corporation and SABiosciences (a QIAGEN Company) have announced that they have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis. These kits are named the RT² Profiler™ PCR Arrays for the Fluidigm BioMark system. Fluidigm Corporation

Poole Hospitals NHS Trust First in the World to Evaluate the Full cobas® 8000 Serum Work Area Solution 07 Apr 2010: Roche is pleased to announce that Poole Hospital NHS Foundation Trust is the first site in the world to evaluate the full serum work area (SWA) capabilities of the cobas® 8000 high throughput clinical analyser. The laboratory at Poole Hospital has now taken delivery of a cobas 8000 SWA platform, incorporating two cobas c701 high throughput clinical chemistry modules together with a cobas e602 immunochemistry module. Roche Diagnostics UK